Journal article
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
- Abstract:
-
BACKGROUND: RTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementation in endemic Africa. Model predictions of impact and cost-effectiveness of this new intervention could aid in country adoption decisions. METHODS: The impact of RTS,S was assessed in 43 countries using an ensemble of models of Plasmodium falciparum epidemiology. Informed by the 32months follow-up data from the phase 3 trial, vaccine effectiveness was evaluated at country levels of malaria parasite ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.2MB)
-
- Publisher copy:
- 10.1016/j.vaccine.2016.11.042
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vaccine Journal website
- Issue:
- 1
- Publication date:
- 2017-01-03
- Acceptance date:
- 2016-11-14
- DOI:
- ISSN:
-
1873-2518 and 0264-410X
- Source identifiers:
-
664296
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:664296
- UUID:
-
uuid:c131592f-dc5a-443e-a87c-9d90fc0ee4e9
- Local pid:
- pubs:664296
- Deposit date:
- 2017-02-01
Terms of use
- Copyright holder:
- Galactionova et al
- Copyright date:
- 2017
- Notes:
-
Copyright 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/). This is the publisher version of the article. This is available online from Elsevier at: https://doi.org/10.1016/j.vaccine.2016.11.042
If you are the owner of this record, you can report an update to it here: Report update to this record